Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Issue: 2011: 106/6 (Dec) pp. 993-1234
Pages: 1012-1019

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options

Executive summary of the report from the 3rd AFNET/EHRA consensus conference

Online Supplementary Material

P. Kirchhof (1, 2, 3), G. Y. H. Lip (3), I. C. Van Gelder (4), J. Bax (5), E. Hylek (6), S. Kääb (7), U. Schotten (8), K. Wegscheider (9), G. Boriani (10), M. Ezekowitz (11), H. Diener (12), H. Heidbuchel (13), D. Lane (3), L. Mont (14), S. Willems (9), P. Dorian (15), P. Vardas (16), G. Breithardt (1, 2), A. J. Camm (17)

(1) Hospital of the University of Münster, Münster, Germany; (2) AFNET, Münster, Germany; (3) University of Birmingham, UK; (4) University of Groningen, The Netherlands; (5) University of Leiden, The Netherlands; (6) Boston University School of Medicine, Boston, Massachusetts, USA; (7) Ludwig Maximilian University Munich, Germany; (8) Maastricht University, The Netherlands; (9) University of Hamburg, Germany; (10) University of Bologna, Italy; (11) Jefferson Medical College, Wynnewood, Pennsylvania, USA; (12) University of Essen, Germany; (13) University Hospital Gasthuisberg, Leuven, Belgium; (14) University of Barcelona, Spain; (15) University of Toronto, Toronto, Canada; (16) University Hospital Heraklion, Crete, Greece; (17) St. George’s University, London, UK


Atrial fibrillation, thrombin, acquired coagulation disorders, Vitamin K-dependent factors, stroke / prevention


There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.

You may also be interested in...

Robert D. McBane 1, David O. Hodge 2, Waldemar E. Wysokinski1

Thromb Haemost 2008 99 5: 951-955


Andreas Greinacher 1, Theodore E. Warkentin2

Thromb Haemost 2008 99 5: 819-829


Frederick A. Ofosu 1, John Freedman 2, John W. Semple2

Thromb Haemost 2008 99 5: 851-862